Neuroprotective Effects of Tripeptides—Epigenetic Regulators in Mouse Model of Alzheimer’s Disease
Animal research · 2021
- What was studied
- 5xFAD mouse model and neuronal research
- Main finding
- Peptides showed no significant LTP restoration. Pooled total spine density differed with EDR but not KED; effects varied by sex and spine subtype.
Long-term potentiation · Peptide-associated trends did not reach statistical significance. The untreated model-versus-wild-type comparison also had p=0.057.
Reported findings and study design
Separate electrophysiology and spine-morphology experiments; each lists four groups of ten mice, five of each sex. Slices/cells are nested observations, not extra animals.
Population or model 5xFAD mouse model and neuronal research
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Long-term potentiation | Peptide-associated trends did not reach statistical significance. The untreated model-versus-wild-type comparison also had p=0.057. | |
| Pooled dendritic spine density, per 10 μm | Vehicle 11.31±0.36; KED 12.48±0.28 (p=0.103); EDR 12.64±0.31 (p=0.039). |
The reported effects varied by sex and spine subtype. Inconsistent subtype values and uncertainty about how the authors analyzed repeated observations within animals limit interpretation.
Source for these results ↗ · Reviewed 2026-11-06
Study limitations and source details
Study limitations
- Mouse findings do not establish human cognitive or Alzheimer’s treatment benefit.
- The report leaves uncertainty about the statistical treatment of cells and slices from the same animal and about inconsistent spine-subtype values.
Source details
Original full XML; neutral electrophysiology and pooled spine-density results checked. Full risk-of-bias assessment remains pending.
Original XML methods and selected results checked
Sources checked
Citation
Author affiliations · St. Petersburg Institute of Bioregulation and Gerontology
Author list available on linked original paper. Neuroprotective Effects of Tripeptides—Epigenetic Regulators in Mouse Model of Alzheimer’s Disease Pharmaceuticals 14(6):515
Study source ↗ · DOI 10.3390/ph14060515 · Bibliography entry · Link to this summary
Related compounds
Pinealon
A synthetic tripeptide, Glu–Asp–Arg (EDR). Researchers have examined its effects in neuronal aging models and measured functional outcomes in human performance studies.
KED
A three-amino-acid peptide (Lys–Glu–Asp) studied in vascular and nerve-cell research and catalogued as Vesugen.